Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is PT Metro Healthcare Indonesia Tbk PS Ratio?
PT Metro Healthcare Indonesia TbkISX:CARE +0.47%78 PS Ratio is 29.47 as of Jul. 17, 2026, which is 41% below its 10-year median of 49.77. GuruFocus rates ISX:CARE with a GF Score™ of 78/100 and a GF Value™ of Rp368.72 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 661 Healthcare Providers & Services companies, PT Metro Healthcare Indonesia Tbk ranks worse than 96.82% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, PT Metro Healthcare Indonesia Tbk's share price is Rp428.00.
PT Metro Healthcare Indonesia Tbk's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was Rp14.53. Hence, PT Metro Healthcare Indonesia Tbk's PS Ratio for today is 29.47.
ISX:CARE'
s PS Ratio Range Over the Past 10 Years
Min: 8.61 Med: 49.77 Max: 79.47
Current: 29.47
During the past 10 years, PT Metro Healthcare Indonesia Tbk's highest PS Ratio was 79.47. The lowest was 8.61. And the median was 49.77.
ISX:CARE's PS Ratio is ranked worse than 96.82% of 661
companies
in the Healthcare Providers & Services industry
Industry Median: 1.52
vs ISX:CARE: 29.47
During the past 10 years, PT Metro Healthcare Indonesia Tbk's highest 3-Year average Revenue per Share Growth Rate was 90.70% per year. The lowest was 3.10% per year. And the median was 19.10% per year.
Back to Basics: PS Ratio
PT Metro Healthcare Indonesia Tbk (ISX:CARE) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
PT Metro Healthcare Indonesia Tbk PS Ratio Related Terms
PT Metro Healthcare Indonesia Tbk PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, PT Metro Healthcare Indonesia Tbk's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Metro Healthcare Indonesia Tbk PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Metro Healthcare Indonesia Tbk's PS Ratio distribution charts can be found below:
* The bar in red indicates where PT Metro Healthcare Indonesia Tbk's PS Ratio falls into.
PT Metro Healthcare Indonesia Tbk PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
PT Metro Healthcare Indonesia Tbk's Share Price of today is Rp428.00. PT Metro Healthcare Indonesia Tbk's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp14.53.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PT Metro Healthcare Indonesia Tbk (ISX:CARE) has a PS Ratio of 29.47 as of Jul. 17, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors. This is 41% below median its historical median of 49.77. Over the past decade, PT Metro Healthcare Indonesia Tbk's PS Ratio has ranged from 8.61 to 79.47. According to the industry distribution chart, PT Metro Healthcare Indonesia Tbk ranks #640 out of 661 companies in the Healthcare Providers & Services industry, placing it in the top 96.8%.
Is PT Metro Healthcare Indonesia Tbk's PS Ratio too high?
PT Metro Healthcare Indonesia Tbk's current PS Ratio of 29.47 is 41% below median its 10-year median of 49.77. Over the past 10 years, this metric has ranged from a low of 8.61 to a high of 79.47. The Healthcare Providers & Services industry median PS Ratio is 1.52. PT Metro Healthcare Indonesia Tbk's value of 29.47 is 1838.8% above this industry median. Based on the distribution chart, PT Metro Healthcare Indonesia Tbk ranks #640 out of 661 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PT Metro Healthcare Indonesia Tbk has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Metro Healthcare Indonesia Tbk's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Metro Healthcare Indonesia Tbk ranks #640 out of 661 companies for PS Ratio. This places PT Metro Healthcare Indonesia Tbk in the lower half of its industry. The industry median PS Ratio is 1.52. PT Metro Healthcare Indonesia Tbk's value of 29.47 is 1838.8% above this benchmark. Historically, PT Metro Healthcare Indonesia Tbk's own PS Ratio has ranged from 8.61 to 79.47 over the past decade. While the company's 10-year median is 49.77 vs. the industry median of 1.52, PT Metro Healthcare Indonesia Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.52, based on 661 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Metro Healthcare Indonesia Tbk's current PS Ratio of 29.47 is 1838.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Metro Healthcare Indonesia Tbk's current PS Ratio is 29.47, which is 41% below median its own 10-year median of 49.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Metro Healthcare Indonesia Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk (ISX:CARE) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp368.72, compared to a current price of Rp428.00 — trading 16.1% above its estimated fair value. The current PS Ratio is 29.47, which is 41% below median its 10-year median of 49.77 and 1838.8% above the Healthcare Providers & Services industry median of 1.52. PT Metro Healthcare Indonesia Tbk's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For PT Metro Healthcare Indonesia Tbk (ISX:CARE), the current PS Ratio is 29.47 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Metro Healthcare Indonesia Tbk (ISX:CARE) Overvalued in 2026?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk stock appears to be overvalued.
The current stock price of Rp428.00 is trading 16.1% above its estimated GF Value™ of Rp368.72.
GuruFocus considers PT Metro Healthcare Indonesia Tbk to be Modestly Overvalued.
Key valuation signals for ISX:CARE:
PS Ratio: 29.47 (41% below median its 10-year median of 49.77)
GF Value™: Rp368.72 vs. price of Rp428.00 (16.1% above fair value)
Industry Position: 1838.8% above the Healthcare Providers & Services median (#640 of 661)
No single metric tells the full story. See the ISX:CARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Metro Healthcare Indonesia Tbk Business Description
PT Metro Healthcare Indonesia Tbk provides integrated health services that consist of hospital and technology-based health services and training centers to produce professionals in health services. The company manages hospitals that are members of the Metro Hospital Group. Its business segment comprises Hospital services and Investment. The majority of revenue is derived from the Hospital services segment that comprises integrated healthcare services for inpatient and outpatient.
78GF Score
Get the complete analysis for ISX:CARE
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:CARE has been successfully added to your 
